Education
About Us
Working with TipRanks
Follow Us
AEON Biopharma (AEON)
:AEON
Total Valuation
AEON Biopharma has a market cap or net worth of $8.89M. The enterprise value is $16.43M.
Market Cap$8.89M
Enterprise Value$16.43M
Share Statistics
AEON Biopharma has 11,643,786 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,643,786
Owned by Insiders15.58%
Owned by Institutions10.03%
Financial Efficiency
AEON Biopharma’s return on equity (ROE) is -1.47 and return on invested capital (ROIC) is -670.45%.
Return on Equity (ROE)-1.47
Return on Assets (ROA)13.37
Return on Invested Capital (ROIC)-670.45%
Return on Capital Employed (ROCE)-6.63
Revenue Per Employee0.00
Profits Per Employee8.40M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AEON Biopharma is <0.1. AEON Biopharma’s PEG ratio is ―.
PE Ratio<0.1
PS Ratio―
PB Ratio―
Price to Fair Value-0.01
Price to FCF―
Price to Operating Cash Flow-0.15
PEG Ratio―
Income Statement
In the last 12 months, AEON Biopharma had revenue of 0.00 and earned 42.01M in profits. Earnings per share was 5.60K.
Revenue0.00
Gross Profit0.00
Operating Income72.98M
Pretax Income42.01M
Net Income42.01M
EBITDA-27.73M
Earnings Per Share (EPS)5.60K
Cash Flow
In the last 12 months, operating cash flow was -13.58M and capital expenditures -4.00K, giving a free cash flow of -13.58M billion.
Operating Cash Flow-13.58M
Free Cash Flow-13.58M
Free Cash Flow per Share-1.17
Dividends & Yields
AEON Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.85
52-Week Price Change-98.61%
50-Day Moving Average0.77
200-Day Moving Average9.35
Relative Strength Index (RSI)50.88
Average Volume (3m)86.96K
Important Dates
AEON Biopharma upcoming earnings date is Nov 18, 2025, Before Open (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
AEON Biopharma as a current ratio of 0.11, with Debt / Equity ratio of -128.94%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap40.06
Net Debt to EBITDA-0.47
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AEON Biopharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AEON Biopharma EV to EBITDA ratio is -0.48, with an EV/FCF ratio of -0.65.
EV to Sales0.00
EV to EBITDA-0.48
EV to Free Cash Flow-0.65
EV to Operating Cash Flow-0.65
Balance Sheet
AEON Biopharma has $8.44M in cash and marketable securities with $16.44M in debt, giving a net cash position of $8.00M billion.
Cash & Marketable Securities$8.44M
Total Debt$16.44M
Net Cash$8.00M
Net Cash Per Share$0.69
Tangible Book Value Per Share-$3.81K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AEON Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-115.39%